Selective Tissue Exposure
Selective Tissue Exposure is a pharmacological strategy that confines the bioavailability of a therapeutic agent to specific target tissues, thereby minimizing systemic exposure and reducing off-target effects while maintaining efficacy at the desired site of action.
16
Publications
525
Citations
109
Authors
33
Institutions
Publications per year
2017–2026
4
Parents
16
1–5 of 16
109
2
h-index
2
h-index
1
h-index
1
h-index
1
h-index
1–5 of 109
33
University at Albany, State University of New York
Albany, United States
2 h-index
7 publications
121 citations
Wadsworth Center
Albany, United States
2 h-index
7 publications
121 citations
New York State Department of Health
Albany, United States
2 h-index
6 publications
98 citations
Mayo Clinic
Rochester, United States
1 h-index
2 publications
38 citations

University Hospital of Bern
Bern, Switzerland
1 h-index
2 publications
78 citations

Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Canada
1 h-index
5 publications
125 citations
Bristol-Myers Squibb (United States)
New York, United States
1 h-index
3 publications
66 citations
Institut de Biologie Moléculaire et Cellulaire
Strasbourg, France
1 h-index
3 publications
117 citations
1–8 of 33
2 publications · 42 citations
2
h-index
JON · 1 publications · 48 citations
1
h-index
1 publications · 56 citations
1
h-index
1 publications · 48 citations
1
h-index
1 publications · 45 citations
1
h-index
1–5